Securecell

For more than 25 years, innovative solutions in bioprocess control have been developed for the biotech and pharmaceutical industries. This expertise and experience form the foundation for the development of Seraccess, a truly disruptive diabetes therapy. Securecell is an expert in process analysis, data processing, and automation within the field of bioprocess engineering. As an engineering company, Securecell develops tailored, comprehensive solutions for complex tasks in bioprocesses. Securecell relies on extensive experience as well as pre-developed modular software and hardware concepts. Securecell's venture division is fundamentally transforming the treatment of diabetes. Out technology is the first and only diabetes treatment technology that directly communicates and interacts with the blood, making it the only solution capable of meeting the requirements of a true artificial pancreas.